11-02-2024, 07:45
The pump and release method (or short interval) has been around for a long time, I haven't read anything controversial about it. In fact I adopted the method over 10 yrs ago. I believe I gained about a cup and a half… I don't pump anymore, I reached my goals (D-cup) in less than two years using NBE, and pumping . A recent 3D mammogram showed my breasts are perfectly healthy. I have roughly 75% heterogeneous breast tissue… meaning i have dense breast tissue. Currently i'm a K-cup. Unfortunately, I was diagnosed with cancer (Leukemia, PH+ chronic myeloid Leukemia… which is a blood cancer that starts in your bone marrow last year). In my case I have a genetic mutation that was discovered last year, in all likelihood I've had Leukemia for a long time but went undetected. My CML has nothing to do with NBE/HRT, confirmed by several doctors (e.g. oncologists, cardiologists, surgeons, primary care provider). Apologies, tmi.
https://www.breastnexum.com/showthread.php?tid=17436&page=479
Imo, the more you pump for extended time periods (e.g. years) you'll develop saggy breasts.
I don't recommend using sunflower oil, it's pro-inflammatory.
Sunflower oil used in high amounts can be pro-inflammatory. Similarly, this can be true when anyone consumes too much omega 6 fatty acids in their diet. Omega 6 needs to balance with omega 3’s. A safe ratio is said to be 1:1, in my own opinion it should be 1:3 (omega 6 to omega 3). Now here's a controversial topic, meaning the controversy over omega 6 consumption to omega 3 (as discussed in this article).
https://www.nutritionadvance.com/omega-6-to-omega-3-ratio/
The research I looked at to prove pumping can be used more than 1-2 times (no more than 15 minutes) is as follows:
Brava and autologous fat grafting for breast reconstruction after cancer surgery
Hirokazu Uda et al. Plast Reconstr Surg. 2014 Feb.
Abstract
Background: Although autologous fat grafting is widely accepted for breast reconstruction, its indications remain limited to minor contour deformities after reconstruction and small deformities after breast-conserving surgery. The authors describe a case series of total or nearly total breast reconstructions treated with the perioperative use of a vacuum-based external tissue expander (i.e., the Brava device) followed by autologous fat grafting.
Methods: The authors assessed the clinical outcomes and aesthetic results in six non irradiated total mastectomy cases and eight severely deformed irradiated breast-conserving surgery cases. Total Brava wearing time and skin complications were also investigated.
Results: The number of fat grafting procedures required ranged from one to four, and the mean amount of fat grafted during each procedure was 256 cc (range, 150 to 400 cc). Postoperative fat lysis and cellulitis occurred in two cases (14.3 percent). Brava worked effectively for total mastectomy cases, and improvement in the total aesthetic score was significantly higher than that in the breast-conserving surgery cases. All patients wore the device for more than 8 hours/day. The most frequent skin complication was dermatitis [n = 11 (79 percent)], which occurred in all breast-conserving surgery cases.
Conclusions: Brava was well tolerated by patients. Fat grafting with perioperative use of Brava is an alternative to total breast reconstruction in total mastectomy cases. However, for severely deformed breast-conserving surgery breasts treated with radiation therapy, the contracted skin was difficult to extend despite Brava use, and the results were less satisfactory. These cases also experienced a higher incidence of skin complications compared with the total mastectomy cases.
https://pubmed.ncbi.nlm.nih.gov/24150122/
The Impact of Recipient Site External Expansion in Fat Grafting Surgical Outcomes
13 studies that applied the BRAVA system reported large fat volume transplantation to the breast (average > 200 cc). The most common complications were localized edema (14.2%), temporary bruising, and superficial skin blisters (11.3%), while the most serious was pneumothorax (0.5%). The majority of the studies reported enhancement of fat graft survival, which ranged between 53% and 82% at 6 months to 1 year follow-up, and high satisfaction of patients and surgeons.
However, although Uda et al.19 discouraged the use of Brava on irradiated tissue for the above-mentioned reasons, Kosowski et al.21 endorsed its use postulating that fat grafting to the irradiated breast could reverse radiation damage to yield superior results.40 Yet, also Kosowski et al.21 outlined that radiated breast tissue is less compliant, with consequent overgrafting and its inherent complications more likely to occur, recommending a greater craftsmanship and experience for a safe and effective execution of the procedure, and performance of multiple treatments (> 4) with small volumes of fat grafting.21
7 authors performed megavolume fat transplant (≥ 300 cc),2,7,11,13–15,17 and almost all the patients (1,272 over 1,274) received an average of more than 200 cc of fat graft per session.
However, after the enthusiasm generated by this first investigations, following researches outlined the limitations of the procedure: only small breast-size enlargement (1 cup) possible, high patient compliance required, patient social life restriction and dropout rates around 25%, 50% of the volume increase only due to swelling at 10 weeks with the suggestion to wear the device for 16–20 weeks.12,22,35–38
And finally:
In 1 article from our group, it was used a smaller device called Kiwi VAC-6000M with a PalmPump (Clinical Innovations, South Murray, Utah), a complete vacuum delivery system, which applies a stronger cycling negative pressure (-550 mm Hg) for a much shorter intraoperative period (10 times for 30 seconds each) on localized scarred recipient sites before autologous fat injection.24
Postoperatively, the Kiwi VAC was applied 3 times per day for 1 minute each for 3 days. The authors reported a gross expansion of tissue, with a macroscopic swelling that regressed slowly after the end of the stimulation, and a small degree of edema, which resolved without sequelae as complication. They also observed satisfactory clinical outcomes, with minimal morbidity and high patient acceptance and compliance.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865941/
https://www.breastnexum.com/showthread.php?tid=17436&page=479
Imo, the more you pump for extended time periods (e.g. years) you'll develop saggy breasts.
I don't recommend using sunflower oil, it's pro-inflammatory.
Sunflower oil used in high amounts can be pro-inflammatory. Similarly, this can be true when anyone consumes too much omega 6 fatty acids in their diet. Omega 6 needs to balance with omega 3’s. A safe ratio is said to be 1:1, in my own opinion it should be 1:3 (omega 6 to omega 3). Now here's a controversial topic, meaning the controversy over omega 6 consumption to omega 3 (as discussed in this article).
https://www.nutritionadvance.com/omega-6-to-omega-3-ratio/
The research I looked at to prove pumping can be used more than 1-2 times (no more than 15 minutes) is as follows:
Brava and autologous fat grafting for breast reconstruction after cancer surgery
Hirokazu Uda et al. Plast Reconstr Surg. 2014 Feb.
Abstract
Background: Although autologous fat grafting is widely accepted for breast reconstruction, its indications remain limited to minor contour deformities after reconstruction and small deformities after breast-conserving surgery. The authors describe a case series of total or nearly total breast reconstructions treated with the perioperative use of a vacuum-based external tissue expander (i.e., the Brava device) followed by autologous fat grafting.
Methods: The authors assessed the clinical outcomes and aesthetic results in six non irradiated total mastectomy cases and eight severely deformed irradiated breast-conserving surgery cases. Total Brava wearing time and skin complications were also investigated.
Results: The number of fat grafting procedures required ranged from one to four, and the mean amount of fat grafted during each procedure was 256 cc (range, 150 to 400 cc). Postoperative fat lysis and cellulitis occurred in two cases (14.3 percent). Brava worked effectively for total mastectomy cases, and improvement in the total aesthetic score was significantly higher than that in the breast-conserving surgery cases. All patients wore the device for more than 8 hours/day. The most frequent skin complication was dermatitis [n = 11 (79 percent)], which occurred in all breast-conserving surgery cases.
Conclusions: Brava was well tolerated by patients. Fat grafting with perioperative use of Brava is an alternative to total breast reconstruction in total mastectomy cases. However, for severely deformed breast-conserving surgery breasts treated with radiation therapy, the contracted skin was difficult to extend despite Brava use, and the results were less satisfactory. These cases also experienced a higher incidence of skin complications compared with the total mastectomy cases.
https://pubmed.ncbi.nlm.nih.gov/24150122/
The Impact of Recipient Site External Expansion in Fat Grafting Surgical Outcomes
13 studies that applied the BRAVA system reported large fat volume transplantation to the breast (average > 200 cc). The most common complications were localized edema (14.2%), temporary bruising, and superficial skin blisters (11.3%), while the most serious was pneumothorax (0.5%). The majority of the studies reported enhancement of fat graft survival, which ranged between 53% and 82% at 6 months to 1 year follow-up, and high satisfaction of patients and surgeons.
However, although Uda et al.19 discouraged the use of Brava on irradiated tissue for the above-mentioned reasons, Kosowski et al.21 endorsed its use postulating that fat grafting to the irradiated breast could reverse radiation damage to yield superior results.40 Yet, also Kosowski et al.21 outlined that radiated breast tissue is less compliant, with consequent overgrafting and its inherent complications more likely to occur, recommending a greater craftsmanship and experience for a safe and effective execution of the procedure, and performance of multiple treatments (> 4) with small volumes of fat grafting.21
7 authors performed megavolume fat transplant (≥ 300 cc),2,7,11,13–15,17 and almost all the patients (1,272 over 1,274) received an average of more than 200 cc of fat graft per session.
However, after the enthusiasm generated by this first investigations, following researches outlined the limitations of the procedure: only small breast-size enlargement (1 cup) possible, high patient compliance required, patient social life restriction and dropout rates around 25%, 50% of the volume increase only due to swelling at 10 weeks with the suggestion to wear the device for 16–20 weeks.12,22,35–38
And finally:
In 1 article from our group, it was used a smaller device called Kiwi VAC-6000M with a PalmPump (Clinical Innovations, South Murray, Utah), a complete vacuum delivery system, which applies a stronger cycling negative pressure (-550 mm Hg) for a much shorter intraoperative period (10 times for 30 seconds each) on localized scarred recipient sites before autologous fat injection.24
Postoperatively, the Kiwi VAC was applied 3 times per day for 1 minute each for 3 days. The authors reported a gross expansion of tissue, with a macroscopic swelling that regressed slowly after the end of the stimulation, and a small degree of edema, which resolved without sequelae as complication. They also observed satisfactory clinical outcomes, with minimal morbidity and high patient acceptance and compliance.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865941/